Market Analysis and Insights: Global Liquid Embolics Market
Due to the COVID-19 pandemic, the global Liquid Embolics market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Isobutyl-2-Cyanoacrylate(IBCA) accounting for % of the Liquid Embolics global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Tumor and Brain Cancer segment is altered to an % CAGR throughout this forecast period.
China Liquid Embolics market size is valued at US$ million in 2021, while the US and Europe Liquid Embolics are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Liquid Embolics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Liquid Embolics include Medtronic, Boston Scientific, Abbott, Cyberonics, Codman & Shurtleff, Stryker, Integra LifeSciences, InoMed and Mizuho America and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Liquid Embolics Scope and Segment
Liquid Embolics market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Liquid Embolics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Isobutyl-2-Cyanoacrylate(IBCA)
Ethanol
Sodium Morrhuate
Bletilla Striata
Others
Segment by Application
Tumor and Brain Cancer
Brain Arteriovenous Malformations
Ischemic Stroke
Brain Aneurysm
Others
By Company
Medtronic
Boston Scientific
Abbott
Cyberonics
Codman & Shurtleff
Stryker
Integra LifeSciences
InoMed
Mizuho America
RauMedic
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE